piracetam has been researched along with Alogia in 15 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In a prospective, double-blind, placebo-controlled study, it was investigated whether piracetam improves language recovery in poststroke aphasia assessed by neuropsychological tests and activation PET measurement of cerebral blood flow." | 9.09 | Piracetam improves activated blood flow and facilitates rehabilitation of poststroke aphasic patients. ( Heiss, WD; Karbe, H; Kessler, J; Thiel, A, 2000) |
| "Electroencephalographic and clinical effects of piracetam in post-stroke aphasia were evaluated in a prospective, randomized, double-blind, placebo-controlled trial." | 9.09 | Restitution of alpha-topography by piracetam in post-stroke aphasia. ( Heiss, WD; Kessler, J; Mielke, R; Szelies, B, 2001) |
| "Piracetam appears to have a positive adjuvant effect on the recovery of aphasia in patients receiving intensive language therapy." | 9.08 | Piracetam as an adjuvant to language therapy for aphasia: a randomized double-blind placebo-controlled pilot study. ( Deberdt, W; Huber, W; Poeck, K; Van Vleymen, B; Willmes, K, 1997) |
| "We performed a systematic review and meta-analysis to assess whether piracetam facilitates the rehabilitation of language performance in post-stroke patients." | 8.93 | Piracetam for Aphasia in Post-stroke Patients: A Systematic Review and Meta-analysis of Randomized Controlled Trials. ( Chen, Z; Luo, B; Wei, R; Zhang, J, 2016) |
| "Piracetam has been shown to improve speech in aphasic patients." | 6.40 | The role of piracetam in the treatment of acute and chronic aphasia. ( Huber, W, 1999) |
| "In a prospective, double-blind, placebo-controlled study, it was investigated whether piracetam improves language recovery in poststroke aphasia assessed by neuropsychological tests and activation PET measurement of cerebral blood flow." | 5.09 | Piracetam improves activated blood flow and facilitates rehabilitation of poststroke aphasic patients. ( Heiss, WD; Karbe, H; Kessler, J; Thiel, A, 2000) |
| "Electroencephalographic and clinical effects of piracetam in post-stroke aphasia were evaluated in a prospective, randomized, double-blind, placebo-controlled trial." | 5.09 | Restitution of alpha-topography by piracetam in post-stroke aphasia. ( Heiss, WD; Kessler, J; Mielke, R; Szelies, B, 2001) |
| "Piracetam appears to have a positive adjuvant effect on the recovery of aphasia in patients receiving intensive language therapy." | 5.08 | Piracetam as an adjuvant to language therapy for aphasia: a randomized double-blind placebo-controlled pilot study. ( Deberdt, W; Huber, W; Poeck, K; Van Vleymen, B; Willmes, K, 1997) |
| "We performed a systematic review and meta-analysis to assess whether piracetam facilitates the rehabilitation of language performance in post-stroke patients." | 4.93 | Piracetam for Aphasia in Post-stroke Patients: A Systematic Review and Meta-analysis of Randomized Controlled Trials. ( Chen, Z; Luo, B; Wei, R; Zhang, J, 2016) |
| "Pharmacotherapy of aphasia had been discussed for the last twenty years with first bromocriptine and amphetamine and then serotoninergic, GABAergic and cholinergic agents." | 4.84 | Pharmacotherapy of aphasia: myth or reality? ( de Boissezon, X; de Boysson, C; Démonet, JF; Peran, P, 2007) |
| "The main conclusion of this review is that drug treatment with piracetam may be effective in the treatment of aphasia after stroke." | 4.81 | Pharmacological treatment for aphasia following stroke. ( Enderby, P; Greener, J; Whurr, R, 2001) |
| "We report the case of an aborted awake craniotomy for a left frontotemporoinsular glioma due to ammonia encephalopathy on a patient taking Levetiracetam, valproic acid and clobazam." | 3.81 | Ammonia encephalopathy and awake craniotomy for brain language mapping: cause of failed awake craniotomy. ( Arroyo Pérez, R; Fernández-Candil, JL; León Jorba, A; Pacreu Terradas, S; Villalba Martínez, G; Vivanco-Hidalgo, RM, 2015) |
| " However, EEG was abnormal and the boy was diagnosed as a case of Landau-Kleffner syndrome (LKS) and treated with sodium valproate, levetiracetam and steroids." | 3.81 | Landau-Kleffner syndrome: an uncommon dealt with case in Southeast Asia. ( Afsar, S; Dixit, NS; Motwani, N; Sharma, N, 2015) |
| "Piracetam has been shown to improve speech in aphasic patients." | 2.40 | The role of piracetam in the treatment of acute and chronic aphasia. ( Huber, W, 1999) |
| "Aphasia is a language disorder characterised by loss of ability to produce or comprehend written or spoken language." | 1.48 | Adult-onset epileptic aphasia. ( Guerra, D; Marques Mendes, E; Mendes, A; Ribeiro, C, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (33.33) | 18.2507 |
| 2000's | 5 (33.33) | 29.6817 |
| 2010's | 5 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marques Mendes, E | 1 |
| Mendes, A | 1 |
| Ribeiro, C | 1 |
| Guerra, D | 1 |
| Villalba Martínez, G | 1 |
| Fernández-Candil, JL | 1 |
| Vivanco-Hidalgo, RM | 1 |
| Pacreu Terradas, S | 1 |
| León Jorba, A | 1 |
| Arroyo Pérez, R | 1 |
| Motwani, N | 1 |
| Afsar, S | 1 |
| Dixit, NS | 1 |
| Sharma, N | 1 |
| Zhang, J | 1 |
| Wei, R | 1 |
| Chen, Z | 1 |
| Luo, B | 1 |
| Güngör, L | 1 |
| Terzi, M | 1 |
| Onar, MK | 1 |
| Schmidtke, K | 1 |
| de Boissezon, X | 1 |
| Peran, P | 1 |
| de Boysson, C | 1 |
| Démonet, JF | 1 |
| Deberdt, W | 3 |
| Huber, W | 2 |
| Willmes, K | 1 |
| Poeck, K | 1 |
| Van Vleymen, B | 1 |
| Enderby, P | 2 |
| Broeckx, J | 1 |
| Hospers, W | 1 |
| Schildermans, F | 1 |
| Orgogozo, JM | 1 |
| Kessler, J | 2 |
| Thiel, A | 1 |
| Karbe, H | 1 |
| Heiss, WD | 2 |
| Szelies, B | 1 |
| Mielke, R | 1 |
| Greener, J | 1 |
| Whurr, R | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Escitalopram and Language Intervention for Subacute Aphasia (ELISA)[NCT03843463] | Phase 2 | 88 participants (Anticipated) | Interventional | 2021-07-18 | Recruiting | ||
| A Randomized Clinical Trial of tDCS to Remediate Phonological Impairment in Aphasia[NCT06010030] | 200 participants (Anticipated) | Interventional | 2023-08-25 | Recruiting | |||
| Effects of tDCS in Language Recovery and Reorganization in Chronic Aphasia[NCT04166513] | 4 participants (Anticipated) | Interventional | 2019-12-01 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for piracetam and Alogia
| Article | Year |
|---|---|
Piracetam for Aphasia in Post-stroke Patients: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
Topics: Aphasia; Humans; Language Disorders; Piracetam; Randomized Controlled Trials as Topic; Stroke; Treat | 2016 |
Pharmacotherapy of aphasia: myth or reality?
Topics: Amphetamine; Aphasia; Bromocriptine; Cholinesterase Inhibitors; Clinical Trials as Topic; Donepezil; | 2007 |
The role of piracetam in the treatment of acute and chronic aphasia.
Topics: Acute Disease; Aphasia; Cerebrovascular Disorders; Chronic Disease; Humans; Nootropic Agents; Pirace | 1999 |
Pharmacological treatment for aphasia following stroke.
Topics: Aphasia; Humans; Neuroprotective Agents; Piracetam; Randomized Controlled Trials as Topic; Stroke | 2001 |
Pharmacological treatment for aphasia following stroke.
Topics: Aphasia; Humans; Neuroprotective Agents; Piracetam; Randomized Controlled Trials as Topic; Stroke | 2001 |
Pharmacological treatment for aphasia following stroke.
Topics: Aphasia; Humans; Neuroprotective Agents; Piracetam; Randomized Controlled Trials as Topic; Stroke | 2001 |
Pharmacological treatment for aphasia following stroke.
Topics: Aphasia; Humans; Neuroprotective Agents; Piracetam; Randomized Controlled Trials as Topic; Stroke | 2001 |
6 trials available for piracetam and Alogia
| Article | Year |
|---|---|
Does long term use of piracetam improve speech disturbances due to ischemic cerebrovascular diseases?
Topics: Aphasia; Female; Humans; Male; Middle Aged; Neuroprotective Agents; Piracetam; Single-Blind Method; | 2011 |
Interaction between psychological and pharmacological treatment in cognitive impairment.
Topics: Adolescent; Aged; Aged, 80 and over; Analysis of Variance; Aphasia; Child; Cognition Disorders; Doub | 1994 |
Piracetam as an adjuvant to language therapy for aphasia: a randomized double-blind placebo-controlled pilot study.
Topics: Adult; Aged; Aphasia; Combined Modality Therapy; Data Interpretation, Statistical; Double-Blind Meth | 1997 |
Effect of piracetam on recovery and rehabilitation after stroke: a double-blind, placebo-controlled study.
Topics: Aged; Aphasia; Cerebral Infarction; Double-Blind Method; Female; Humans; Male; Middle Aged; Neuropro | 1994 |
Piracetam improves activated blood flow and facilitates rehabilitation of poststroke aphasic patients.
Topics: Adolescent; Adult; Aged; Aphasia; Brain; Cerebrovascular Circulation; Combined Modality Therapy; Dou | 2000 |
Restitution of alpha-topography by piracetam in post-stroke aphasia.
Topics: Adult; Aged; Analysis of Variance; Aphasia; Brain Mapping; Double-Blind Method; Electroencephalograp | 2001 |
5 other studies available for piracetam and Alogia
| Article | Year |
|---|---|
Adult-onset epileptic aphasia.
Topics: Aged; Anticonvulsants; Aphasia; Cerebral Cortex; Electroencephalography; Epilepsy; Female; Humans; L | 2018 |
Ammonia encephalopathy and awake craniotomy for brain language mapping: cause of failed awake craniotomy.
Topics: Anesthesia, General; Anesthesia, Local; Anticonvulsants; Aphasia; Benzodiazepines; Brain Diseases; B | 2015 |
Landau-Kleffner syndrome: an uncommon dealt with case in Southeast Asia.
Topics: Anticonvulsants; Aphasia; Asia, Southeastern; Child; Electroencephalography; Humans; Landau-Kleffner | 2015 |
[Does treatment with piracetam in stroke patients with aphasia make sense?].
Topics: Aphasia; Humans; Neuroprotective Agents; Nootropic Agents; Piracetam; Stroke | 2002 |
Piracetam in the treatment of acute stroke.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Aphasia; Cerebrovascular Disorders; Female; Humans; M | 1999 |